145 related articles for article (PubMed ID: 29169619)
1. Immunohistochemical Validation of Spontaneously Arising Canine Osteosarcoma as a Model for Human Osteosarcoma.
Al-Khan AA; Gunn HJ; Day MJ; Tayebi M; Ryan SD; Kuntz CA; Saad ES; Richardson SJ; Danks JA
J Comp Pathol; 2017 Nov; 157(4):256-265. PubMed ID: 29169619
[TBL] [Abstract][Full Text] [Related]
2. The use of alkaline phosphatase and runx2 to distinguish osteosarcoma from other common malignant primary bone tumors in dogs.
Barger A; Baker K; Driskell E; Sander W; Roady P; Berry M; Schnelle A; Fan TM
Vet Pathol; 2022 May; 59(3):427-432. PubMed ID: 35253545
[TBL] [Abstract][Full Text] [Related]
3. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
4. Diversity of Histologic Patterns and Expression of Cytoskeletal Proteins in Canine Skeletal Osteosarcoma.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Kadosawa T; Taniyama H
Vet Pathol; 2015 Sep; 52(5):977-84. PubMed ID: 25770040
[TBL] [Abstract][Full Text] [Related]
5. Fibroblastic Subtype has a Favourable Prognosis in Appendicular Osteosarcoma of Dogs.
Al-Khan AA; Nimmo JS; Day MJ; Tayebi M; Ryan SD; Kuntz CA; Simcock JO; Tarzi R; Saad ES; Richardson SJ; Danks JA
J Comp Pathol; 2020 Apr; 176():133-144. PubMed ID: 32359626
[TBL] [Abstract][Full Text] [Related]
6. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
[TBL] [Abstract][Full Text] [Related]
7. Detection of alkaline phosphatase in canine cells previously stained with Wright-Giemsa and its utility in differentiating osteosarcoma from other mesenchymal tumors.
Ryseff JK; Bohn AA
Vet Clin Pathol; 2012 Sep; 41(3):391-5. PubMed ID: 22676437
[TBL] [Abstract][Full Text] [Related]
8. A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.
Wagner F; Holzapfel BM; Martine LC; McGovern J; Lahr CA; Boxberg M; Prodinger PM; Grässel S; Loessner D; Hutmacher DW
Acta Biomater; 2019 Apr; 89():372-381. PubMed ID: 30836200
[TBL] [Abstract][Full Text] [Related]
9. RUNX2 and Osteosarcoma.
Li N; Luo D; Hu X; Luo W; Lei G; Wang Q; Zhu T; Gu J; Lu Y; Zheng Q
Anticancer Agents Med Chem; 2015; 15(7):881-7. PubMed ID: 25738872
[TBL] [Abstract][Full Text] [Related]
10. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
11. The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.
Neumann ZL; Pondenis HC; Masyr A; Byrum ML; Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(6):1584-94. PubMed ID: 26426813
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL.
Marley K; Bracha S; Seguin B
Exp Cell Res; 2015 Oct; 338(1):32-8. PubMed ID: 26254896
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma.
Won KY; Park HR; Park YK
Tumori; 2009; 95(3):311-6. PubMed ID: 19688969
[TBL] [Abstract][Full Text] [Related]
15. A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models.
Mayordomo E; Machado I; Giner F; Kresse SH; Myklebost O; Carda C; Navarro S; Llombart-Bosch A
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):453-61. PubMed ID: 20436344
[TBL] [Abstract][Full Text] [Related]
16. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
17. Role of osteopontin in osteosarcoma.
Li YS; Deng ZH; Zeng C; Lei GH
Med Oncol; 2015 Jan; 32(1):449. PubMed ID: 25516504
[TBL] [Abstract][Full Text] [Related]
18. Tumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequency.
de Sá Rodrigues LC; Holmes KE; Thompson V; Newton MA; Stein TJ
Vet Comp Oncol; 2017 Mar; 15(1):78-93. PubMed ID: 25689105
[TBL] [Abstract][Full Text] [Related]
19. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical analysis to evaluate an inverse correlation between Runx2/Cbfa1 and NF kappa B in human osteosarcoma.
Andela VB; Siddiqui F; Groman A; Rosier RN
J Clin Pathol; 2005 Mar; 58(3):328-30. PubMed ID: 15735172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
